Breast Augmentation Incisions: Why Where the Scar Goes Is the Least of What the Incision Decides, Why the Route Through the Nipple Carries More Than a Scar, and Why the Armpit Scar Is Hard to Reuse

The breast augmentation incision is the first decision most patients feel entitled to make for themselves. Implant size is negotiated with the surgeon, the pocket plane is a technical call, and the profile of the device is a catalog discussion. But the scar is theirs to live with, and so the conversation usually begins with a question about where it will show: under the breast, around the nipple, in the armpit, or, for a small number of practices, at the navel.

It is a reasonable question. It is also the smallest part of what the incision actually decides. The opening an implant passes through determines how clearly the surgeon can see the pocket being built, how much of the patient's own bacterial population the implant brushes against on the way in, which implants can physically fit through it, and whether the same opening can be reused a decade later when the implant needs to be exchanged, removed, or repositioned. Those consequences are not cosmetic, and several of them outlast the scar's visibility by years.

This piece works through the four approaches, what each one trades, and the questions that separate a considered choice from a preference about scar placement.

What the breast augmentation incision actually decides, beyond the scar

The short answer: the incision controls access to the pocket, exposure of the implant to bacteria, the size and type of implant that can be used, and the ease of any future revision, and those four factors usually matter more to the long-term result than where the scar sits.

Start with access. An augmentation is, mechanically, the construction of a pocket precisely matched to the implant, in a chosen plane, with borders that will hold for years. The article on breast implant malposition makes the point that almost every implant that "moved" was sitting in a pocket that was built or later stretched to the wrong shape. How well that pocket is built depends heavily on how directly the surgeon can see and reach its borders, especially the inframammary fold, which is the single most important boundary in the operation. An incision placed at the fold sits a few centimeters from the structure it has to define. An incision at the nipple or in the armpit has to work toward it from a distance.

Then contamination. The leading theory of capsular contracture, laid out in the piece on what the evidence shows about contracture, holds that low levels of bacteria reaching the implant at the time of surgery can form a biofilm that drives chronic inflammation and thickening of the scar capsule. Breast tissue itself is not sterile: the milk ducts that open at the nipple host skin bacteria, including coagulase-negative staphylococci and Cutibacterium acnes. An incision that passes through breast tissue to reach the pocket gives those organisms more opportunity to meet the implant.

Then fit. A silicone gel implant arrives prefilled and has to be passed through the opening intact, which means the incision has to be long enough for the device. A larger or more cohesive implant needs a longer opening, and the most form-stable shaped devices, described in the piece on round versus teardrop implants, need the longest. A saline implant is inserted empty and filled in place, so it can go through a much smaller opening, which is one of the few areas where the choice described in the saline versus silicone comparison interacts directly with the incision.

And finally, the future. The Food and Drug Administration is explicit in its patient information that breast implants are not lifetime devices, and the piece on whether implants need to be replaced walks through why many patients will have at least one further operation. The question is not only whether the first operation goes well but whether the opening chosen for it will serve the second.

The inframammary fold incision: why the default is the default, and where it goes wrong

The short answer: the incision in the crease beneath the breast is the most common approach because it gives the most direct view of the pocket, avoids cutting through breast tissue, accommodates any implant type, and can be reused for revisions, and its weaknesses are a scar that is visible when the breast is lifted or when the patient is lying down, and a scar that can end up in the wrong place if the fold is misjudged.

The inframammary approach places a short incision in or just above the fold, usually offset slightly toward the outer side of the breast. From there the surgeon reaches the pocket without passing through the glandular tissue, which keeps the implant away from the ducts and the bacteria they carry. The fold, the medial border near the breastbone, and the lateral border toward the armpit can all be seen and controlled directly, and bleeding points can be managed under direct vision. Any implant, including large silicone devices and form-stable shaped implants, can be placed through it, and the same scar can be reopened for an exchange, a capsule repair, or removal.

That combination is why a widely cited infection-control checklist published in 2006, often called the 14-point plan, lists the inframammary incision among its steps, alongside antibiotic pocket irrigation, nipple shields to keep ductal fluid off the field, and minimizing handling of the implant before it goes in. Several large datasets, including multi-year follow-up from the manufacturers' premarket studies, have found lower capsular contracture rates with the fold incision than with the periareolar or axillary routes. The comparisons are observational, and surgeons who favor other incisions argue that technique rather than route explains much of the gap, but the direction of the finding has been consistent enough that the fold has become the default in most training programs.

The weaknesses are real. The scar is hidden when the patient is standing in a bra or bikini, but it is visible from below, when the arms are raised, or when lying flat, and in patients with very little breast tissue and no natural crease, it can be visible from the front. It can also migrate. If the fold is lowered to accommodate an implant, as the tissue-based sizing systems in the piece on how surgeons decide implant size sometimes require, the incision has to be placed at the new fold, not the old one. A scar placed at the original crease will ride up onto the lower breast as the implant settles, where it looks like a scar rather than a shadow. And like any chest incision, it can thicken: the chest is one of the regions most prone to hypertrophic scarring and keloid formation, a risk that matters most for patients with a personal history of keloids and is discussed in the piece on procedures on deeper skin tones.

The periareolar incision: the camouflaged scar, the ducts, and what travels with them

The short answer: an incision along the lower border of the areola can hide well at the color change between areola and skin, but it requires passing through or around breast tissue that carries bacteria, it is limited by the size of the areola, and it has been associated in several studies with higher capsular contracture and, in some, with more breastfeeding difficulty.

The appeal of the periareolar incision is optical. A scar placed exactly at the junction of the darker areola and the lighter surrounding skin can become nearly invisible, and it puts the opening in the center of the breast, which gives reasonable access to both the upper and lower pocket. It is also the natural route when a patient needs a small lift or areola reduction at the same time, a situation covered in the piece on combining a lift with implants.

The costs are less visible. To reach the pocket from the areola, the surgeon either cuts through the gland or tunnels around it, and either way the implant passes close to ductal tissue. That is the mechanism behind the association with capsular contracture, and it is why many surgeons who use the approach pair it with nipple shields, insertion sleeves, and meticulous irrigation. The areola also sets a hard limit on the length of the incision. A small areola may simply not offer enough perimeter to pass a large silicone implant without forcing it, and squeezing a gel implant through too small an opening is a recognized way to stress the shell.

Scar quality on the areola is usually good, but not always. The scar can lighten, widen, or distort the round border, which is harder to correct than a fold scar and more noticeable in patients whose areola is sharply defined against the surrounding skin.

The breastfeeding question is contested. The piece on breastfeeding after breast surgery sets out the evidence: some studies found periareolar approaches most strongly linked with lactation insufficiency, while a later meta-analysis did not find that the periareolar incision specifically reduced breastfeeding rates, and insufficiency was elevated even after incisions that never went near the ducts. Nipple sensation is similarly less tied to the incision than folklore suggests. The main sensory nerve to the nipple, the lateral branch of the fourth intercostal nerve, enters from the outer side of the breast, and studies of sensory change after augmentation have tended to implicate larger implants and wide lateral pocket dissection more than incision location. The broader picture of numbness after surgery is in the piece on numbness after plastic surgery.

"

The scar is the part of the incision a patient will see. The pocket, the bacteria, and the next operation are the parts the incision actually decides.

"

The armpit and the navel: no breast scar, less control, and a harder second operation

The short answer: the transaxillary incision in the armpit and the transumbilical incision at the navel both leave the breast itself unscarred, but they require the surgeon to build the pocket from a distance, they have historically been linked to more implants sitting too high, and a revision almost always needs a new incision on the breast anyway.

The transaxillary approach places the incision in a natural crease of the armpit. Surgeons then tunnel toward the chest and create the pocket, usually beneath the muscle. Done bluntly, without a camera, the lower pocket and fold are hard to define precisely, which is why older series reported implants that sat high and required repositioning. Endoscopic assistance, where a camera is passed through the tunnel so the surgeon can see and release the muscle attachments and control bleeding, has narrowed that gap considerably in practiced hands. The appeal for patients who never want a scar on the breast itself is legitimate, and it can be a good choice for a patient with a well-defined fold, a modest implant, and a surgeon who does many of them.

Its limitations appear later. Reaching the pocket from the armpit for a revision is difficult, particularly for contracture or malposition that requires work at the fold, so most surgeons revising an axillary augmentation make a new incision at the fold or the areola. The patient who chose the armpit to avoid a breast scar often ends up with both. The armpit scar is also visible in sleeveless clothing when the arm is raised, and armpit skin is prone to darkening in patients with deeper skin tones. Some surgeons raise a concern about disturbing the lymphatic channels used for sentinel node mapping should breast cancer ever occur; the evidence on that point is limited, and it is a fair question to ask, particularly for patients with a strong family history. Swelling in the armpit after surgery can also be confused with other things, including the accessory breast tissue described in the piece on the armpit lump.

The transumbilical approach, sometimes called TUBA, goes further: the implant is placed through a small incision in the navel and pushed up a tunnel beneath the abdominal skin. It is used only with saline implants, inserted empty and filled once they are in position, because a prefilled silicone implant cannot be passed that way and the silicone device labeling does not support the route. Pocket creation is blind or nearly so, the fold is defined by expansion rather than dissection, and any revision has to be done through a new incision on the breast. It is a niche technique with a small number of devoted practitioners, and it deserves more skepticism than enthusiasm from a patient who is not already committed to saline.

How the choice should actually be made

The short answer: the right incision follows from the implant, the breast's shape, the patient's scar history, and the likelihood of future revision, and a surgeon who offers every incision equally for every patient, or who offers only one without explaining why, is not giving the patient the reasoning behind the choice.

The implant comes first. A patient set on a larger silicone implant or a form-stable shaped device is realistically choosing between the fold and, if the areola is large enough, the periareolar route. A patient choosing saline has more options, and should understand why. Insertion sleeves, the funnel-style devices designed to pass a silicone implant through the opening with minimal contact with the skin, have made shorter incisions possible and reduce handling, but they do not change the underlying trade-offs of each route.

The breast comes next. A tight lower pole, a constricted base, or a fold that needs to be lowered or reshaped, as with the tuberous breast deformity, makes direct access to the fold more valuable. A breast that also needs a lift already has an areolar incision in the plan, which changes the calculation. Where the pocket will sit matters too: the renewed interest in placing implants above the muscle, discussed in the piece on the prepectoral shift, puts even more weight on precise fold and border control.

The patient's history matters. Anyone with a history of keloids or thick scars should know which chest and armpit sites are highest risk, and should see how the surgeon manages scars in the months afterward, along the lines of the piece on scar care. Patients planning pregnancy and breastfeeding should hear an honest account of what is and is not known.

And revision planning matters more than patients expect. Implants require ongoing monitoring, including the imaging schedules described in the piece on long-term implant surveillance, and a meaningful share of patients will have another operation. A fold incision is the most reusable, the areola is reusable with limits, and the armpit and navel generally are not. Infection-control measures matter regardless of route; the piece on staph decolonization before surgery covers one step some practices add, and the piece on antibiotics after surgery covers another that is often overused.

The honest summary

The breast augmentation incision is usually chosen for where the scar will show, and it deserves to be chosen for what it does. The inframammary fold incision is the default because it gives the most direct control of the pocket, keeps the implant away from the bacteria carried in the milk ducts, fits any implant, and can be reused, at the cost of a scar that shows from below and that can land in the wrong place if the fold is lowered without moving it. The periareolar incision can hide beautifully at the edge of the areola, but it passes through or near ductal tissue, it is limited by the areola's size, and it has been associated with more capsular contracture in several datasets. The armpit and navel routes spare the breast a scar while making the pocket harder to build precisely and the next operation harder to perform, and the navel route works only with saline. None of these is wrong for every patient, and a skilled surgeon can get good results through any of them. The mistake is treating the choice as cosmetic when it is structural. Pick the incision for the pocket and the future, and the scar, wherever it goes, tends to take care of itself.